Introduction to Rare Metabolic Disorders

Inborn errors of metabolism, although individually rare, collectively have a significant incidence1. These disorders typically result from genetic mutations that affect the coding of various enzymes, thereby impairing the body’s ability to metabolize specific substances.

This impairment can lead to harmful accumulations or deficiencies of these substances2,3. The impact of these disorders can be seen across multiple metabolic pathways, resulting in a diverse array of symptoms that may affect several organ systems. Due to their rarity, these metabolic disorders are often undiagnosed or misdiagnosed, which can lead to delays in treatment and management. Understanding these conditions is essential for early detection and intervention and for providing necessary support and education to affected individuals and their families.

The inherited metabolic disorders are internationally classified using the International Classification of Inherited Metabolic Disorders (ICIMD), a comprehensive and hierarchical system developed to categorize them based on their biochemical, clinical, and pathophysiological features4. Below is a table comprising various rare metabolic disorders, their categories, and their respective incidence rates.

Table 1: Metabolic disorders, categories and incidence.

CategoryDisorderIncidence
Amino Acid DisordersPhenylketonuria (PKU)1 in 10,000 to 15,000 births
Maple syrup urine disease (MSUD)1 in 185,000 births
Homocystinuria1 in 200,000 to 335,000 births
Tyrosinemia type I1 in 100,000 to 120,000 births
Organic AcidemiasMethylmalonic acidemia1 in 50,000 to 100,000 births
Propionic acidemia1 in 100,000 births
Isovaleric acidemia1 in 250,000 births
Urea Cycle DisordersOrnithine transcarbamylase (OTC) deficiency1 in 80,000 births
Citrullinemia1 in 57,000 births
Fatty Acid Oxidation DisordersMedium-chain acyl-CoA dehydrogenase (MCAD) deficiency1 in 15,000 births
Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency1 in 100,000 births
Carbohydrate DisordersGalactosemia1 in 30,000 to 60,000 births
Hereditary fructose intolerance1 in 20,000 births
Lysosomal Storage DisordersFabry disease1 in 40,000 to 60,000 males
Gaucher disease1 in 50,000 to 100,000 births
Niemann-Pick disease1 in 250,000 births
Pompe disease1 in 40,000 births
Peroxisomal DisordersZellweger syndrome1 in 50,000 births
X-linked adrenoleukodystrophy1 in 21,000 males
Mitochondrial DisordersLeigh syndrome1 in 40,000 births
MELAS syndrome1 in 6,650 to 29,000 births

References

1.            Saudubray, J.-M., de Baulny, H. O. & Charpentier, C. Clinical Approach to Inherited Metabolic Diseases. in Inborn Metabolic Diseases: Diagnosis and Treatment (eds. Fernandes, J., Saudubray, J.-M., Van den Berghe, G., Tada, K. & Buist, N. R. M.) 3–39 (Springer, Berlin, Heidelberg, 1995). doi:10.1007/978-3-662-03147-6_1.

2.            Arnold, G. L. Inborn errors of metabolism in the 21st century: past to present. Ann Transl Med 6, 467 (2018).

3.            Lee, N. & Kim, D. Toxic Metabolites and Inborn Errors of Amino Acid Metabolism: What One Informs about the Other. Metabolites 12, 527 (2022).

4.            Ferreira, C. R., Rahman, S., Keller, M., Zschocke, J. & Group, I. A. An international classification of inherited metabolic disorders (ICIMD). Journal of Inherited Metabolic Disease 44, 164–177 (2021).

Leave a comment